This clinical research study is to evaluate a new investigational medication to assess if it reduces the risk of a major cardiovascular (heart related) event in patients with a history of severe high triglycerides (greater than 500).
This important study is designed to evaluate a new investigational medication for the treatment of heavy periods in women with suspected or known uterine fibroids to see if it decreases heavy periods and reduces the size of uterine fibroids.
